Newsroom

Sorted by: Latest

-

Kaleon S.p.A. : AGENDA FINANCIER 2026

MILAN--(BUSINESS WIRE)--Regulatory News: Conformément aux obligations d'information prévues par l'article 17 du Règlement des émetteurs sur Euronext Growth Milan, Kaleon S.p.A. (“Kaleon” ou la “Société”) (Paris:ALKLN) (MIL:KLN), société contrôlée par la famille Borromeo, spécialisée dans la gestion et la valorisation touristique du patrimoine artistique, naturel et culturel, annonce la publication de son agenda financier pour 2026. Dates Evènements 16 février 2026 Conseil d'administration – App...
-

Hoffmann Green Accelerates Its Diversification Into New Markets With the Signing of a Partnership Agreement With Groupe GSE, a Leading General Contractor in France and Europe

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative cold produced, clinker-free cements, announces the signing of a strategic partnership with GSE, a leading general contractor for almost 50 years, to support the decarbonization of its industrial and co...
-

WE.CONNECT : BILAN ANNUEL AU 31 DECEMBRE 2025 DU CONTRAT DE LIQUIDITE WE.CONNECT

PARIS--(BUSINESS WIRE)--Regulatory News: Au titre du contrat de liquidité confié par WE.CONNECT (Paris:ALWEC) à TSAF – Tradition Securities And Futures, les moyens suivants figuraient au compte de liquidité en date du 31/12/2025 : 2 022 actions WE.CONNECT 96 023,91 € Il est rappelé que, lors du bilan semestriel au 30/06/2025, les moyens suivants figuraient au compte de liquidité : 1 823 actions WE.CONNECT 100 073,08 € Au cours du 2ème semestre 2025, il a été négocié par le contrat de liquidité...
-

Hoffmann Green accélère sa diversification des marchés adressés avec la signature d’un partenariat avec le Groupe GSE, contractant général de premier plan en France et en Europe

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News :  Hoffmann Green Cement Technologies (ISIN : FR0013451044, Mnémo : ALHGR) (« Hoffmann Green Cement » ou la « Société »), acteur industriel engagé dans la décarbonation du secteur de la construction qui conçoit et commercialise des ciments innovants sans clinker, annonce la signature d’un partenariat stratégique avec GSE, contractant général de premier plan depuis près de 50 ans, afin d’accompagner la décarbonation de ses actifs...
-

Castles Technology Partners With Loomis Pay to Power European Expansion With Next-Generation Android Devices

VÉLIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Castles Technology has been selected by Loomis Pay to support its European expansion....
-

Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 26 January 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 26 January 2026 Number of Public Shares Purchased: 17...
-

Artajasa, the Largest Operator of Indonesia’s QRIS, and Ant International Launch Global Payments and Digital Finance Partnership

SINGAPORE--(BUSINESS WIRE)--PT Artajasa Pembayaran Elektronis (“Artajasa”), Indonesia’s leading payment system infrastructure provider, has entered into a Memorandum of Understanding (MoU) with Ant International, a leading global digital payment, digitisation and financial technology provider. This strategic collaboration will advance the integration of seamless cross-border payment, AI-powered mobile innovations, and SME digtialisation solutions between Indonesia and Ant International’s extens...
-

Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical trial of CT-388, an investigational dual GLP-1/GIP receptor agonist being developed for the treatment of obesity. The study found that once-weekly subcutaneous injections of CT-388 (titrated up to 24 mg) resulted in significant and clinically meaningful placebo-adjusted weight loss of 22.5% (efficacy estim...
-

ProPetro Holding Corp. Announces Pricing of Upsized Public Offering of Common Stock

MIDLAND, Texas--(BUSINESS WIRE)--ProPetro Holding Corp. Announces Pricing of Upsized Public Offering of Common Stock...
-

Ant Group Subsidiary Robbyant Unveils Spatial Perception AI Model LingBot-Depth

SHANGHAI--(BUSINESS WIRE)--Robbyant, an embodied AI company within Ant Group, today open-sourced LingBot-Depth, a high-precision spatial perception model designed to enhance robots’ depth sensing and 3D environmental understanding capabilities in complex real-world environments. In parallel, Robbyant announced a plan to form a strategic partnership with Orbbec, a leading provider of robotics and AI vision. As part of this collaboration, Orbbec will integrate LingBot-Depth into its next-generati...